Pablo Tebas

19.9k citations
214 papers · 10.6k · 3 hit papers · h-index 54

Impact in

Papers in

    • HIV/AIDS drug development and treatment 99
    • HIV/AIDS Research and Interventions 51
    • HIV Research and Treatment 111

Pablo Tebas

209 papers receiving 10.3k citations

Pablo Tebas's Hit Papers

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial 2017 · 257 citations
2570+5+10Years since publication250500750

Peers

Pablo Tebas
Comparison fields: 5 of 134
  • Virology 4.3k
  • Emergency Medicine 4.7k
  • Infectious Diseases 5.4k
  • Orthopedics and Sports Medicine 1.5k
  • Hepatology 549
Replace Jennifer Hoy with:
Jennifer Hoy Australia
Willy Rozenbaum France
Jack Fuhrer United States
Andrew Carr Australia
Jan Gerstoft Denmark
Niels Obel Denmark
Adriano Lazzarin Italy
Marshall J. Glesby United States
Michael A. Polis United States
Kiat Ruxrungtham Thailand
Pablo Tebas relative to Jennifer Hoy Australia Jennifer Hoy's profile →
Citations per field
00.5×3.0×
Jennifer Hoy · 1×
Citations per year

Countries citing papers authored by Pablo Tebas

Since Specialization
Citations

This map shows the geographic impact of Pablo Tebas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Tebas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Tebas more than expected).

Fields of papers citing papers by Pablo Tebas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Tebas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Tebas. The network helps show where Pablo Tebas may publish in the future.

Co-authors

The 25 scholars most cited alongside Pablo Tebas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pablo Tebas Line = papers co-authored together Pablo Tebas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 214 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Hit paper breakdown →
2014973
2 2000437
3
Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
Hit paper breakdown →
2011381
4 2010297
5
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
Hit paper breakdown →
2017257
6 1998254
7 2003243
8 2012240
9 2007173
10 2003165
11 2005157
12 2012154
13 2010150
14
A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia.
2005150
15 2016145
16 1999137
17 2002127
18 2009120
19 2007119
20 2005117

About Pablo Tebas

Pablo Tebas is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Epidemiology and Immunology, having authored 214 papers that have together received 10.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (111 papers), HIV/AIDS drug development and treatment (99 papers), HIV-related health complications and treatments (87 papers), HIV/AIDS Research and Interventions (51 papers), Immune Cell Function and Interaction (22 papers), Bone and Joint Diseases (22 papers), Hepatitis C virus research (16 papers) and Cytomegalovirus and herpesvirus research (11 papers). The work is most often cited by research in Virology (4.3k citations), Emergency Medicine (4.7k citations), Infectious Diseases (5.4k citations), Orthopedics and Sports Medicine (1.5k citations) and Hepatology (549 citations). Pablo Tebas has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include William G. Powderly, Kevin E. Yarasheski, Grace A. McComsey, Sherry Claxton, Kristin Mondy, Ian Frank, Woraphot Tantisiriwat, Roger Bedimo, Henning Drechsler and Edgar T. Overton. Their work appears in journals such as AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, Clinical Infectious Diseases, The Journal of Infectious Diseases and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact